United States - English - NLM (National Library of Medicine)

cardinal health - methylprednisolone sodium succinate (unii: lec9gky20k) (methylprednisolone - unii:x4w7zr7023) - methylprednisolone 125 mg in 2 ml - when oral therapy is not feasible, and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intravenous or  intramuscular use of methylprednisolone sodium succinate for injection, usp sterile powder is indicated as follows: allergic states : control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases : bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders : primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplemen

United States - English - NLM (National Library of Medicine)

sagent pharmaceuticals - methylprednisolone acetate (unii: 43502p7f0p) (methylprednisolone - unii:x4w7zr7023) - when oral therapy is not feasible and the strength, dosage form, and route of administration of the drug reasonably lend the preparation to the treatment of the condition, the intramuscular use of methylprednisolone acetate injectable suspension, sterile aqueous suspension, is indicated as follows: allergic states: control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions. dermatologic diseases: bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders: primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adre

United States - English - NLM (National Library of Medicine)

pharmadel llc - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - purpose external analgesic for the temporary relief of minor aches and pains of muscles and joints associated with: - simple backache - arthritis - strains - sprains

United States - English - NLM (National Library of Medicine)

whitestone products llc - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - topical analgesic topical analgesic for temporary relief of minor aches and pains associated with simple backaches, arthritis, bruises, sprains and cramps.

United States - English - NLM (National Library of Medicine)

l'bris, pure 'n natural - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), capsaicin (unii: s07o44r1zm) (capsaicin - unii:s07o44r1zm) - methyl salicylate 100 mg in 1 ml - for the temporary relief of minor aches and pains of the muscles and joints associated with arthritis, simple backache, sprains, bruises and strains.

United States - English - NLM (National Library of Medicine)

cersci therepeutics, inc. - methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - methyl salicylate 100 mg in 1 g - for the temporary relief of minor aches and pains of muscles and joints associated with:• simple back ache • arthritis • strains • bruises and • sprains

United States - English - NLM (National Library of Medicine)

laderma trading pty ltd - methyl salicylate (unii: lav5u5022y) (methyl salicylate - unii:lav5u5022y) - methyl salicylate 105 mg in 1 g - pain relieving - for the temporary relief of minor aches and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains.

United States - English - NLM (National Library of Medicine)

international nature nutraceuticals - camphor (natural) (unii: n20hl7q941) (camphor (natural) - unii:n20hl7q941), menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a), methyl salicylate (unii: lav5u5022y) (salicylic acid - unii:o414pz4lpz) - for the temporary relief of minor aches and pains of muscles and joints due to: - simple backache - arthritis - strains - bruises - sprains - on wounds - on irritated or damaged skin - if the appearance of this product has changed - in excess of 12 hours - if known sensitivity this product pregnant, or taking other medications - condition worsens - symptoms persist for more than 7 days - symptoms clear up and occur again within a few days - excessive irritation of the skin develops when using for pain of arthritis - pain persists for more than 10 days - redness is present - in conditions affecting children under 12 years of age

United States - English - NLM (National Library of Medicine)

royal labs natural cosmetics - menthol 10%, methyl salicylate 10%, camphor bark oil 3%, eucalyptus leaf oil 2% - directions: adults and children 12 years of age and older: rub onto affected area 3 to 4 times daily; children under 12 years of age ask a doctor. uses: for temporary relief of minor aches and pains of muscles and joints associated with: arthritis, muscle strain, bruises, sprains, backache

United States - English - NLM (National Library of Medicine)

henan lingrui pharmaceutical co.; ltd - camphor 3.0%, menthol 1.5%, methyl salicylate 2.5% - camphor   external analgesic menthol     external analgesic methyl salicylate   external analgesic to relieve the rheumatic pain and arthralgia by promoting blood circulation, used for rheumatoid arthristis muscular aches, sprain etc. do not use on wounds. on irritated or damaged skin if the apperance of this product has changed in excess of 12 hours if you have know hypersensitivities to this product otherwise than as directed pregnent taking other medications condition worsens symptonms persist for more than 7 days symptoms clear up and occur again within 1 few days excessive irritation of the skin develops when using for pain of arthritis pain persists for more than 10 days redness is present in conditions affecting children under 12 years adults and children 12 years of age and older: apply one or two plasters to affected area once a day. remove after 12 hours. children 2 to 12 years of age and adults with compromised health: use only under the guidance of a doctor. children under 2 years of age: do not